927 related articles for article (PubMed ID: 35046929)
1. The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS).
König RS; Albrich WC; Kahlert CR; Bahr LS; Löber U; Vernazza P; Scheibenbogen C; Forslund SK
Front Immunol; 2021; 12():628741. PubMed ID: 35046929
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis.
Du Preez S; Corbitt M; Cabanas H; Eaton N; Staines D; Marshall-Gradisnik S
Syst Rev; 2018 Dec; 7(1):241. PubMed ID: 30572962
[TBL] [Abstract][Full Text] [Related]
3. Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Shukla SK; Cook D; Meyer J; Vernon SD; Le T; Clevidence D; Robertson CE; Schrodi SJ; Yale S; Frank DN
PLoS One; 2015; 10(12):e0145453. PubMed ID: 26683192
[TBL] [Abstract][Full Text] [Related]
4. Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome.
Giloteaux L; Goodrich JK; Walters WA; Levine SM; Ley RE; Hanson MR
Microbiome; 2016 Jun; 4(1):30. PubMed ID: 27338587
[TBL] [Abstract][Full Text] [Related]
5. Does the microbiome and virome contribute to myalgic encephalomyelitis/chronic fatigue syndrome?
Newberry F; Hsieh SY; Wileman T; Carding SR
Clin Sci (Lond); 2018 Mar; 132(5):523-542. PubMed ID: 29523751
[TBL] [Abstract][Full Text] [Related]
6. Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome.
Nagy-Szakal D; Williams BL; Mishra N; Che X; Lee B; Bateman L; Klimas NG; Komaroff AL; Levine S; Montoya JG; Peterson DL; Ramanan D; Jain K; Eddy ML; Hornig M; Lipkin WI
Microbiome; 2017 Apr; 5(1):44. PubMed ID: 28441964
[TBL] [Abstract][Full Text] [Related]
7. A Narrative Review on Gut Microbiome Disturbances and Microbial Preparations in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Long COVID.
Jurek JM; Castro-Marrero J
Nutrients; 2024 May; 16(11):. PubMed ID: 38892479
[TBL] [Abstract][Full Text] [Related]
8. Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis/chronic fatigue syndrome: neuropsychological symptoms and sex comparisons.
Wallis A; Ball M; Butt H; Lewis DP; McKechnie S; Paull P; Jaa-Kwee A; Bruck D
J Transl Med; 2018 Feb; 16(1):24. PubMed ID: 29409505
[TBL] [Abstract][Full Text] [Related]
9. Examining clinical similarities between myalgic encephalomyelitis/chronic fatigue syndrome and D-lactic acidosis: a systematic review.
Wallis A; Ball M; McKechnie S; Butt H; Lewis DP; Bruck D
J Transl Med; 2017 Jun; 15(1):129. PubMed ID: 28592308
[TBL] [Abstract][Full Text] [Related]
10. Clinical evidence of the link between gut microbiome and myalgic encephalomyelitis/chronic fatigue syndrome: a retrospective review.
Wang JH; Choi Y; Lee JS; Hwang SJ; Gu J; Son CG
Eur J Med Res; 2024 Mar; 29(1):148. PubMed ID: 38429822
[TBL] [Abstract][Full Text] [Related]
11. Potential role of microbiome in Chronic Fatigue Syndrome/Myalgic Encephalomyelits (CFS/ME).
Lupo GFD; Rocchetti G; Lucini L; Lorusso L; Manara E; Bertelli M; Puglisi E; Capelli E
Sci Rep; 2021 Mar; 11(1):7043. PubMed ID: 33782445
[TBL] [Abstract][Full Text] [Related]
12. The gastrointestinal microbiota in the development of ME/CFS: a critical view and potential perspectives.
Stallmach A; Quickert S; Puta C; Reuken PA
Front Immunol; 2024; 15():1352744. PubMed ID: 38605969
[TBL] [Abstract][Full Text] [Related]
13. Investigating Antibody Reactivity to the Intestinal Microbiome in Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Feasibility Study.
Seton KA; Defernez M; Telatin A; Tiwari SK; Savva GM; Hayhoe A; Noble A; de Carvalho-KoK ALS; James SA; Bansal A; Wileman T; Carding SR
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895005
[TBL] [Abstract][Full Text] [Related]
14. Deficient butyrate-producing capacity in the gut microbiome is associated with bacterial network disturbances and fatigue symptoms in ME/CFS.
Guo C; Che X; Briese T; Ranjan A; Allicock O; Yates RA; Cheng A; March D; Hornig M; Komaroff AL; Levine S; Bateman L; Vernon SD; Klimas NG; Montoya JG; Peterson DL; Lipkin WI; Williams BL
Cell Host Microbe; 2023 Feb; 31(2):288-304.e8. PubMed ID: 36758522
[TBL] [Abstract][Full Text] [Related]
15. Multi-'omics of gut microbiome-host interactions in short- and long-term myalgic encephalomyelitis/chronic fatigue syndrome patients.
Xiong R; Gunter C; Fleming E; Vernon SD; Bateman L; Unutmaz D; Oh J
Cell Host Microbe; 2023 Feb; 31(2):273-287.e5. PubMed ID: 36758521
[TBL] [Abstract][Full Text] [Related]
16. High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients.
Frémont M; Coomans D; Massart S; De Meirleir K
Anaerobe; 2013 Aug; 22():50-6. PubMed ID: 23791918
[TBL] [Abstract][Full Text] [Related]
17. Eukaryotes in the gut microbiota in myalgic encephalomyelitis/chronic fatigue syndrome.
Mandarano AH; Giloteaux L; Keller BA; Levine SM; Hanson MR
PeerJ; 2018; 6():e4282. PubMed ID: 29375937
[TBL] [Abstract][Full Text] [Related]
18. The Emerging Role of Gut Microbiota in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Current Evidence and Potential Therapeutic Applications.
Varesi A; Deumer US; Ananth S; Ricevuti G
J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768601
[TBL] [Abstract][Full Text] [Related]
19. Mitochondria and immunity in chronic fatigue syndrome.
Anderson G; Maes M
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Dec; 103():109976. PubMed ID: 32470498
[TBL] [Abstract][Full Text] [Related]
20. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease.
Arron HE; Marsh BD; Kell DB; Khan MA; Jaeger BR; Pretorius E
Front Immunol; 2024; 15():1386607. PubMed ID: 38887284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
